BlackRock’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BlackRock’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-440,600	Closed	-$32.7M	–	5946
2022 Q2	$32.7M	Buy	+440,600	New	+$33.1M	﹤0.01%	2784
2022 Q1	–	Sell	-1,747,800	Closed	-$196M	–	5917
2021 Q4	$196M	Buy	+1,747,800	New	+$211M	0.01%	1748

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BlackRock's XBI Position: Q2 2026 in Review

BlackRock increased its State Street SPDR S&P Biotech ETF (XBI) stake by 247% in Q2 2026, buying an estimated $49.6M and bringing the position to 516,032 shares worth $81.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

BlackRock first reported a position in XBI in Q3 2019 and has held it in 27 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

BlackRock held 516,032 shares of State Street SPDR S&P Biotech ETF worth $81.7M as of Q2 2026.
BlackRock bought 367,215 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $49.6M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2347 holding.
BlackRock first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 27 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.